Welcome to the ASCEPT-MPGPCR Joint Scientific Meeting 2016
On behalf of the Program Committee, we invite you to attend the ASCEPT-MPGPCR Joint Scientific Meeting to be held at the Melbourne Convention and Exhibition Centre from 27 – 30 November 2016.
The meeting represents the second joint venture between the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Molecular Pharmacology of GPCRs (MPGPCR) meeting. The theme for this meeting is Therapeutic targeting: right place, right time, right effect.
We anticipate that there will be approximately 350-400 attendees at the meeting from Australia, New Zealand, Asia, Europe and the United States. These world-class experts, early career researchers and students are all actively engaged in either academic or industrial pre-clinical and clinical pharmacology with a large number focussed on GPCR research.
The meeting offers the opportunity to network with colleagues and other leading international and national scientists and academics at both social and scientific activities. A key feature of the meeting is the chance for early career researchers and research students to present their research findings in poster and oral presentations sessions. Annual awards and prizes from both ASCEPT and MPGPCR will also be presented at this meeting.
The program of plenary lectures, symposia and workshops, oral presentations and posters will be scientifically stimulating and lead to new collaborations and research opportunities.
We welcome our many international guests and hope you will join us in Melbourne.
|Prof Dom Geraghty
|Dr Chris Langmead
|Dr Angela Finch
Who should attend:
• academic and industrial scientists associated with discovery, formulation and the delivery of drugs
• clinicians involved in the prescription and/or review of therapeutic agents
• regulatory and clinical scientists involved in drug development and drug registration
• researchers in clinical pharmacy, pharmacology and toxicology
• education providers in pharmacy, pharmacology and toxicology
• students and postdoctoral fellows from Australia and New Zealand in all areas of the pharmaceutical sciences
• government agencies involved in chemical safety assessment and registration
• medical practitioners such as clinical pharmacologists, clinical toxicologists, cardiologists and general physicians
• molecular and cellular pharmacologists.